Alterations of DNA methylation and clinicopathological diversity of human cancers.
about
Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancerA perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomicsWhole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot studyThe tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissueDiagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification.Genetic and epigenetic alterations during renal carcinogenesis.Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterationsCurrent concepts on dedifferentiation/high-grade transformation in salivary gland tumors.NNK-induced DNA methyltransferase 1 in lung tumorigenesis in A/J mice and inhibitory effects of (-)-epigallocatechin-3-gallate.Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer.Genetically engineered mouse models in cancer researchDNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcomeAbsence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.Biomarkers of the metabolic syndrome and breast cancer prognosis.Multilayer-omics analyses of human cancers: exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium.In utero exposure to maternal smoking is associated with DNA methylation alterations and reduced neuronal content in the developing fetal brain.DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.CHFR: a key checkpoint component implicated in a wide range of cancers.Modifiable risk factors in periodontal disease: epigenetic regulation of gene expression in the inflammatory response.Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion.Organomegaly and tumors in transgenic mice with targeted expression of HpaII methyltransferase in smooth muscle cellsMethylation status of WWOX gene promoter CpG islands in epithelial ovarian cancer and its clinical significanceDnmt3a-CD is less susceptible to bulky benzo[a]pyrene diol epoxide-derived DNA lesions than prokaryotic DNA methyltransferases.Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage.Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues.Expression and function role of DNA methyltransferase 1 in human bladder cancer.Promoter methylation of , an antisense transcript of p53, is associated with the poor prognosis of patients with non-small cell lung cancer
P2860
Q26827297-B4001FE1-600D-4B2C-85FA-B83BFF0D7A31Q26852571-45595FD0-24BF-47AD-8C4C-BE75702442AFQ28729757-B2A410C8-F835-4F86-8167-DF1BDD17ECE7Q33604936-81054C1F-6B6B-4CEA-91C1-43A2FC085466Q33643873-29EA24B9-4A1F-4DCC-8F85-1FCE9824C9B9Q34014559-BCFA5C74-4C44-487C-84B9-53F957CBFA46Q34203924-7E8B2586-2D99-4683-A425-3521EAD5141EQ34442914-EFCC166A-17F1-42AA-BC4C-0580D0B69668Q34467232-FD790233-4819-4C2F-988C-EF8199C5AC9DQ34734078-ADC2D8E1-1CDC-41B6-89FB-8BB5604308C7Q35176500-24A8F6AB-53C2-45A1-A38E-C97E98E74960Q35189140-E9EB9247-4505-493A-99DF-6CFBE52E5EE1Q36145645-7341187C-3CD0-479C-8F00-C888C7AF9BD0Q36163659-4EF3C9A5-4DB4-4B7C-8EA5-5EBBE7A5CE77Q36414395-A206B7CF-AA71-48A9-A43B-EFECA13479F2Q36497718-BC18F2FA-A027-4068-A396-EA487BDC2DB0Q36721411-66155D30-476D-4CCE-847A-185F93FDCDA1Q37090440-0BD82457-4EE4-436F-8606-F407AF5754C2Q37318009-62C279F1-F3EE-4CD9-8E31-972E9126C7A9Q37328339-0753FADE-F6DA-4303-ACEE-67667E2EC76EQ37583117-1FBD8ABD-1DBA-4B5D-839B-0E31107365E2Q37609817-A5F1A503-72FB-4251-A9AE-F7AE015E446AQ37961740-6BCE2F7A-6A47-4AD6-9E1B-48BD14C445B8Q37967195-072D050F-ACF7-449F-97D2-73AC9CE3353CQ38169800-8128299F-B82F-44EC-A323-7A096E557408Q39246449-4110535C-995E-48C7-92C2-A0C9F7FFCD9AQ39627734-B35604CC-2680-47ED-9F94-C4A0768BC0C0Q41845064-F0778ABA-7530-4219-8DB2-187D8D0FB70AQ42716819-5915BC52-EA07-4DEC-BCF8-B8AF4F70AC00Q44643066-D7054262-6F07-4673-9023-B9FB8B0C935EQ53255401-0A8BD0F6-0E99-45E1-A6BE-2F4D42E1C3EFQ54594046-BAF9B23B-F377-4DD1-BB64-E85D13B1838DQ57788760-00D42BD2-5BE8-4376-8D06-8EE2605F7916
P2860
Alterations of DNA methylation and clinicopathological diversity of human cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alterations of DNA methylation and clinicopathological diversity of human cancers.
@en
Alterations of DNA methylation and clinicopathological diversity of human cancers.
@nl
type
label
Alterations of DNA methylation and clinicopathological diversity of human cancers.
@en
Alterations of DNA methylation and clinicopathological diversity of human cancers.
@nl
prefLabel
Alterations of DNA methylation and clinicopathological diversity of human cancers.
@en
Alterations of DNA methylation and clinicopathological diversity of human cancers.
@nl
P2860
P1476
Alterations of DNA methylation and clinicopathological diversity of human cancers.
@en
P2093
P2860
P304
P356
10.1111/J.1440-1827.2008.02270.X
P577
2008-09-01T00:00:00Z